1.
Natural history of acute and chronic hepatitis C
by Maasoumy, Benjamin, MD
Baillière's best practice & research. Clinical gastroenterology, 2012, Vol.26 (4), p.401-412
2.
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews
by Nelson, Paul K, MHSc
The Lancet (British edition), 2011, Vol.378 (9791), p.571-583
3.
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
by Dolan, Kate, Prof
The Lancet (British edition), 2016, Vol.388 (10049), p.1089-1102
4.
Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence
by Candotti, Daniel
Gut, 2012, Vol.61 (12), p.1744-1753
5.
Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017
by Ork, Vichit
Vaccine, 2019, Vol.37 (35), p.5059-5066
6.
Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992–2015
by Childs, Lana
Vaccine, 2018, Vol.36 (1), p.6-14
7.
Identification and impact of hepatitis B virus DNA and antigens in pancreatic cancer tissues and adjacent non-cancerous tissues
by Jin, Yan
Cancer letters, 2013, Vol.335 (2), p.447-454
8.
Occult HBV infection
by Raimondo, Giovanni
Seminars in immunopathology, 2012, Vol.35 (1), p.39-52
9.
Seroepidemiology of hepatitis B virus infection in 2 million men aged 21–49 years in rural China: a population-based, cross-sectional study
by Liu, Jue, PhD
The Lancet infectious diseases, 2016, Vol.16 (1), p.80-86
10.
The global impact of vaccination against hepatitis B: A historical overview
by Zanetti, Alessandro R
Vaccine, 2008, Vol.26 (49), p.6266-6273
11.
Chronic hepatitis B reactivation following infliximab therapy in Crohn’s disease patients: need for primary prophylaxis
by Esteve, M
Gut, 2004, Vol.53 (9), p.1363-1365
12.
Changing epidemiology of hepatocellular carcinoma in Asia
by Goh, George Boon-Bee, MBBS, MMed, MRCP (UK)
Baillière's best practice & research. Clinical gastroenterology, 2015, Vol.29 (6), p.919-928
13.
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy
by Loras, C
Gut, 2010, Vol.59 (10), p.1340-1346
14.
Hepatitis A and B among young persons who inject drugs—Vaccination, past, and present infection
by Collier, Melissa G
Vaccine, 2015, Vol.33 (24), p.2808-2812
15.
Hepatitis B virus infection
by Liaw, Yun-Fan, Prof
The Lancet (British edition), 2009, Vol.373 (9663), p.582-592
16.
Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis
by Zoutendijk, Roeland
Gut, 2013, Vol.62 (5), p.760-765
17.
18.
Viral hepatitis B
by Lai, Ching Lung
The Lancet (British edition), 2003, Vol.362 (9401), p.2089-2094
19.
Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?
by Janssen, Harry L A
Gut, 2012, Vol.61 (5), p.641-645
20.
Hepatitis B surface antibodies seroprevalence among people born before and after implementation of universal HBV vaccination
by Di Lello, Federico A
Vaccine, 2020, Vol.38 (12), p.2678-2682
